Osteogenesis imperfecta type 15 is a rare genetic condition that causes fragile bones and frequent fractures. Features often include bone pain, short stature, and curvature of the spine, and some people have blue-tinted sclera or hearing changes. It is lifelong and usually recognized in childhood, but severity can vary widely. Many people with osteogenesis imperfecta type 15 live into adulthood, though serious complications can occur with severe forms. Care focuses on fracture prevention, pain control, physical therapy, mobility aids, and sometimes surgery and bone-strengthening medicines.
Overview
Osteogenesis imperfecta type 15Symptoms
Osteogenesis imperfecta type 15 causes fragile bones with frequent fractures, low bone density, and bone deformities. Many have short stature, spinal curvature, and chest or limb bowing; some develop hearing or dental issues. Signs appear in infancy or early childhood.
Outlook and prognosis
Most people with Osteogenesis imperfecta type 15 live into adulthood, but bone fragility can lead to repeated fractures, pain, and height loss. With careful fracture prevention, physical therapy, and tailored orthopedic care, mobility and independence often improve. Severity varies widely between families and even within the same family.
Causes and risk factors
Osteogenesis imperfecta type 15 stems from WNT1 gene variants, usually autosomal recessive or occasionally new. Family history and parental relatedness increase risk. Nutrition, glucocorticoids, and low activity don’t cause it but may worsen bone fragility.
Genetic influences
Genetics are central in Osteogenesis imperfecta type 15. Pathogenic variants in specific genes disrupt collagen-related pathways, driving bone fragility and related features. Inherited patterns vary by family; genetic testing confirms the diagnosis, informs prognosis, and guides family planning and eligibility for trials.
Diagnosis
Doctors suspect it from frequent fractures, short stature, or low bone density on scans and X-rays. Genetic tests confirm the specific type. This approach—clinical features plus testing—supports the genetic diagnosis of Osteogenesis imperfecta type 15.
Treatment and drugs
Treatment for osteogenesis imperfecta type 15 focuses on strengthening bones, easing pain, and preventing fractures. Care often combines tailored physiotherapy, vitamin D and calcium, bisphosphonates, and careful fracture management; some benefit from bracing or corrective surgery. Regular hearing, dental, and spine checks guide adjustments over time.
Symptoms
People living with Osteogenesis imperfecta type 15 tend to have very fragile bones that break more easily than expected, which can affect everyday activities from walking to lifting a backpack. For some families, the early features of Osteogenesis imperfecta type 15 show up in infancy or early childhood as repeated fractures or slow recovery after minor falls. Features vary from person to person and can change over time. Care focuses on protecting bones, easing pain, and supporting growth and movement.
Bones can break after small bumps, short falls, or routine play. In Osteogenesis imperfecta type 15, fractures often happen in different bones over time. This can lead to activity limits and more time spent healing.
Achy or sharp pain may follow a break and can linger during healing. Some people have ongoing soreness in the legs, back, or hips between fractures. Pain often flares with activity and eases with rest and supports.
Bones are less dense and more fragile than expected for age. Doctors may see this on scans that measure bone strength. Lower density helps explain why fractures occur more easily.
The long bones of the legs or arms can curve over time. This may change the way someone stands or walks. Bracing or surgery is sometimes used to improve alignment.
How people usually first notice Osteogenesis imperfecta type 15?
Many families first notice something is wrong during pregnancy or soon after birth, when ultrasounds or early X‑rays show unusually fragile bones, healed fractures, or bone deformities that seem out of proportion to any injury. In babies and toddlers, the first signs of osteogenesis imperfecta type 15 often include frequent fractures with minor falls, blue or gray tint to the whites of the eyes, and slower-than-expected growth, prompting doctors to check bone density and consider genetic testing. Sometimes the condition is first noticed later in childhood when repeated fractures, limb bowing, or delayed motor milestones lead to an evaluation for brittle bone disease.
Types of Osteogenesis imperfecta type 15
Osteogenesis imperfecta type 15 is a genetic form of brittle bone disease with features that can vary from person to person. People with this condition often share core traits like fragile bones and short stature, but the severity and extra features can differ. Clinicians often describe them in these categories:
Classical features
Frequent bone fractures start in childhood and may lessen after puberty. Shorter height and curved bones can develop over time. Blue or grey-tinted whites of the eyes may be present.
Moderate severity
Fractures occur with minor falls, but many keep good mobility with supports. Spine curves and hearing changes may appear later. Dental enamel may chip or wear down more easily.
Severe presentation
Bones may break before or soon after birth, with limb bowing. Growth is more limited and surgeries are often needed. Breathing or feeding problems can occur in infancy.
Milder end
Fewer fractures and near-average height are possible. People may first notice issues during sports or after a low-impact injury. Early symptoms of osteogenesis imperfecta type 15 can be subtle.
What genetics can tell you about symptoms
Some people with osteogenesis imperfecta type 15 have brittle bones, short stature, blue-gray sclerae, and hearing loss because variants in the WNT1 gene weaken signaling that helps build strong bone. When WNT1 doesn’t work well, bones fracture easily and grow less dense over time.
Causes and risk factors
Osteogenesis imperfecta type 15 is caused by harmful changes in the WNT1 gene that disrupt bone formation.
Most cases happen when both parents carry a WNT1 change and each passes it to their child.
Risk is higher in families where early symptoms of osteogenesis imperfecta type 15 have appeared, and when parents are related by blood.
Low vitamin D, smoking, or long-term steroid use do not cause it but can worsen bone fragility.
Doctors distinguish between risk factors you can change and those you can’t.
Environmental and biological risk factors
Osteogenesis imperfecta type 15 is usually present from conception, so risk factors relate to influences before pregnancy rather than during fetal development. Doctors often group risks into internal (biological) and external (environmental). For this condition, known risk factors are limited and mostly tied to things that can create new changes in sperm or eggs. Below are environmental and biological risk factors for Osteogenesis imperfecta type 15 that researchers consider relevant.
As men age, new changes occur more often in sperm cells. This can slightly raise the chance of a one-time, spontaneous case of Osteogenesis imperfecta type 15. The overall risk remains low.
High-dose ionizing radiation to a parent before conception can increase changes in sperm or eggs. This may very slightly increase the chance of Osteogenesis imperfecta type 15 in a future pregnancy. Care teams often suggest waiting a recommended period after radiation therapy before trying to conceive.
Certain cancer medicines can affect sperm or egg quality and increase the chance of new changes. If used shortly before conception, there may be a small increase in risk, though the absolute risk is still low. Your oncology team can advise on timing to reduce this risk.
Jobs with ionizing radiation can expose reproductive cells if protection is inadequate. Following strict safety measures keeps exposure very low and reduces risk. If there were high or accidental exposures, a clinician can review whether any added risk applies.
Genetic risk factors
Osteogenesis imperfecta type 15 is linked to changes in a single gene that helps bones form and stay strong. These changes are usually inherited in an autosomal recessive way, meaning both copies of the gene must carry a change. Severity can vary, even among relatives with the same genetic changes. In some cases, genetic testing can give a clearer picture of your personal risk.
WNT1 gene changes: WNT1 gene changes disrupt bone-building signals and are the main genetic cause. Most people with osteogenesis imperfecta type 15 have two disease-causing changes, one on each copy of WNT1. This can weaken bone formation from early life.
Recessive inheritance: Both parents are usually healthy carriers of one WNT1 change. Each pregnancy has a 25% (1 in 4) chance of a child with osteogenesis imperfecta type 15. Unaffected siblings may still be carriers.
Carrier state effects: Having one WNT1 change (carrier status) usually does not cause osteogenesis imperfecta type 15. Some carriers can develop lower-than-average bone density or early-onset osteoporosis in adulthood. This carrier effect is separate from the recessive form that causes OI type 15.
Family history clues: A history of an affected sibling points to both parents carrying a WNT1 change. When parents are related or come from the same small community, the chance they share the same change is higher. This raises the likelihood of another child with the condition.
Founder variants: In certain families or regions, a shared ancestor can lead to a higher frequency of a specific WNT1 change. This clustering can increase the chance that two carriers have children together. Genetic counseling can explain how this applies to your background.
Variable severity: Severity and early symptoms of osteogenesis imperfecta type 15 can differ even within one family. The same WNT1 changes may lead to different fracture rates or bone shape differences between relatives. This variability can make individual risk predictions less precise.
Children’s risk: A person living with osteogenesis imperfecta type 15 will pass one WNT1 change to all children. If their partner is a carrier, each child has a 50% chance to be affected and a 50% chance to be a carrier. If the partner is not a carrier, all children will be carriers but typically not affected.
Lifestyle risk factors
Osteogenesis imperfecta type 15 is a genetic bone fragility condition; lifestyle habits do not cause it. Still, daily choices can shape fracture risk, mobility, and recovery. Understanding how lifestyle affects Osteogenesis imperfecta type 15 can help you build safer routines. The elements below emphasize behaviors that may reduce complications.
Jumping, contact, and collision sports sharply raise fracture risk. Choose low-impact options like swimming, cycling with support, or water therapy to build endurance safely.
Light, supervised resistance work can improve muscle support around fragile bones. Heavy loads or poor technique may trigger fractures and should be avoided.
Consistent, guided exercises improve balance, gait, and joint stability, which can lower falls. Skipping therapy leads to deconditioning and higher fracture risk.
Adequate protein, calcium, and vitamin D support bone mineralization and healing after fractures. Severe dieting or poor appetite can slow recovery and worsen bone fragility.
Risk prevention
You can’t prevent osteogenesis imperfecta type 15, but you can lower the chance of fractures and other complications. Prevention is about lowering risk, not eliminating it completely. Knowing early symptoms of osteogenesis imperfecta type 15 and acting quickly—like treating pain, protecting a limb, or calling your care team—can make a real difference. The best plan blends safe movement, bone health, fall prevention, and regular medical follow-up.
Use gentle lifting, avoid twisting, and support the whole body during transfers. Teaching family, school staff, and caregivers these techniques reduces fracture risk in osteogenesis imperfecta type 15.
Low-impact, guided exercises build strength and balance without overloading fragile bones. Water therapy and tailored weight-bearing activities can support mobility and confidence.
Make home and school safer with clear walkways, non-slip mats, and good lighting. Supportive footwear and vision checks help prevent trips and falls.
Bone-strengthening medicines, like bisphosphonates, may reduce fracture risk when prescribed by a specialist. Calcium and vitamin D are often recommended, but dosing should match age and lab levels.
Transmission
Osteogenesis imperfecta type 15 is not an infection—you can’t catch it or pass it to others. Instead, it runs in families because of a change in a gene that helps build strong bone; genetic transmission of Osteogenesis imperfecta type 15 is usually autosomal recessive, meaning both parents carry one changed copy but don’t have symptoms.
When two carriers have a child, each pregnancy has a 25% (1 in 4) chance the child will have Osteogenesis imperfecta type 15, a 50% (1 in 2) chance the child will be a carrier like the parents, and a 25% (1 in 4) chance the child will inherit neither changed copy. Sometimes it shows up in a family with no known history, either because carrier status wasn’t recognized or because a new gene change occurred. A genetic counselor can explain how Osteogenesis imperfecta type 15 is inherited and discuss testing for relatives and future pregnancies.
When to test your genes
Consider genetic testing if you have frequent low‑impact fractures, blue‑tinged sclerae, short stature, or a family history of osteogenesis imperfecta, especially if symptoms began in childhood. Testing can confirm type 15, guide bone‑strengthening care, tailor surgical planning, and inform pregnancy and family decisions. It’s also reasonable before starting high‑risk sports or orthopedic procedures.
Diagnosis
Frequent fractures from minor bumps, slow recovery, or back pain from compressed vertebrae often bring people to care. Doctors confirm the genetic diagnosis of osteogenesis imperfecta type 15 with DNA testing after initial clinical clues. Getting a diagnosis is often a turning point toward answers and support. Tests help separate this condition from other causes of fragile bones so treatment and bone-protection plans can start sooner.
Doctors look for a history of fractures with minimal trauma, reduced height over time, and signs of bone deformity such as curved long bones or spinal changes. They also check for features sometimes seen in osteogenesis imperfecta, like short stature or ligament laxity.
Standard X-rays show current and healed fractures, bone shape, and vertebral compression. Imaging helps distinguish patterns typical of osteogenesis imperfecta type 15 from injuries due to other causes.
A DXA scan measures bone mineral density at the spine and hips. Low bone density supports the diagnosis, especially when paired with a fracture history.
A blood or saliva test looks for changes (variants) in the WNT1 gene, which are linked with osteogenesis imperfecta type 15. Finding a disease-causing variant confirms the diagnosis and can guide family testing.
Stages of Osteogenesis imperfecta type 15
Osteogenesis imperfecta type 15 does not have defined progression stages. It’s a lifelong genetic condition, and how it shows up can vary widely, with some people having frequent childhood fractures that ease after puberty while others have milder features, so doctors follow changes over time rather than labeling stages. Diagnosis usually combines your medical history and exam with imaging like X‑rays and bone density scans, and Genetic testing may be offered to clarify certain risks. When early symptoms of osteogenesis imperfecta type 15 include repeated bone fractures, bone pain, or slower growth, follow‑up visits help monitor bone health and guide treatment.
Outlook and prognosis
Living with Osteogenesis imperfecta type 15, day-to-day life often centers on preventing fractures, staying mobile, and managing pain. Many people ask, “What does this mean for my future?”, and the honest answer is that strength, fracture frequency, and independence can vary widely. Everyone’s journey looks a little different.
Doctors call this the prognosis—a medical word for likely outcomes. In general, earlier diagnosis and consistent care are linked with better function, fewer fractures over time, and greater participation in school, work, and family life. Early care can make a real difference, including bone-strengthening medicines, tailored physical therapy, safe movement strategies, and prompt fracture care.
For many with Osteogenesis imperfecta type 15, life span is near typical, especially when severe chest or spine problems are avoided and respiratory health is protected; serious complications are more likely if frequent fractures, significant scoliosis, or reduced lung capacity develop. Some people experience repeated fractures in childhood that lessen after puberty, while others notice a steadier pattern across adulthood. Knowing what to expect can ease some of the worry.
Looking at the long-term picture can be helpful. With ongoing care, many people maintain active lives, use mobility aids as needed, and plan around periods of recovery. Ask about early symptoms of Osteogenesis imperfecta type 15 that signal higher fracture risk—such as new bone pain, changes in posture, or a run of minor breaks—so your team can adjust treatment early.
In medical terms, the long-term outlook is often shaped by both genetics and lifestyle. Genetic testing can sometimes provide more insight into prognosis, but not everyone with the same gene change will have the same outlook. Talk with your doctor about what your personal outlook might look like, including bone density goals, fall-prevention plans, and how to handle emergencies at home or school.
Long-term effects
Daily life with fragile bones can mean planning around bumps, falls, and long recovery times after injuries. Long-term effects vary widely, and they don’t look the same for everyone. While early symptoms of osteogenesis imperfecta type 15 may involve frequent fractures in childhood, the long-term picture centers on bone strength, spine shape, and mobility. Over time, the condition can influence growth, posture, hearing, and lung function to different degrees.
Bones break more easily than average throughout life. Fractures may occur after minor falls or everyday activities. Healing can lead to changes in bone shape over time.
Repeated fractures and uneven healing can bend long bones. This may be most noticeable in the legs and arms. Over years, alignment changes can affect posture and balance.
Scoliosis or kyphosis can develop as vertebrae compress and reshape. Curves in the spine may slowly increase with growth or aging. This can influence comfort and stamina when sitting or standing.
Limited bone growth and vertebral compression can reduce adult height. People with osteogenesis imperfecta type 15 may be shorter than family members. Height can also change over time due to spine compression.
How is it to live with Osteogenesis imperfecta type 15?
Living with osteogenesis imperfecta type 15 often means planning around bone fragility and fatigue while still finding ways to stay active and connected. Many navigate frequent medical visits, mobility aids, and careful movement to prevent fractures, and some adjust homes, school, or work to reduce falls and strain. Family, friends, and coworkers may take on supportive roles—helping with transportation, lifting tasks, or adapting activities—while learning how to offer help without limiting independence. With consistent care, physical therapy, and good communication, many build routines that protect bones, manage pain, and keep everyday life meaningful and social.
Treatment and drugs
Treatment for Osteogenesis imperfecta type 15 focuses on strengthening bone, preventing fractures, easing pain, and supporting mobility through a personalized plan. Doctors often start with physical therapy to build muscle support, safe weight-bearing exercises, and mobility aids like braces or walkers; medicines that strengthen bone, such as bisphosphonates, are commonly used in children and sometimes adults to reduce fracture risk. Pain management may include acetaminophen or NSAIDs, with careful monitoring, and a doctor may adjust your dose to balance benefits and side effects. Orthopedic surgery—such as rods placed inside long bones or procedures to correct curved limbs—can help stabilize bones and improve function, while dental and hearing care address features that sometimes come along with OI. Alongside medical treatment, lifestyle choices play a role, including fall-prevention at home, adequate calcium and vitamin D, and regular follow-up with a team familiar with Osteogenesis imperfecta type 15.
Non-drug treatment
Living with frequent fractures and muscle weakness can shape daily life, school, and work. Alongside medicines, non-drug therapies help protect bones, improve mobility, and lower fracture risk over time. Early symptoms of Osteogenesis imperfecta type 15—like repeated breaks after minor bumps and delayed walking—also guide which supports to start first. Care plans are individualized and often blend therapy, equipment, and education.
Gentle, tailored exercises build muscle strength and balance without overloading fragile bones. Therapists teach safe movement patterns to reduce falls and protect healing limbs.
Water supports body weight so joints and bones take less stress while you move. Pool sessions can improve endurance, flexibility, and confidence with fewer bumps and stumbles.
Skills training helps with dressing, bathing, writing, and school or work tasks in safer ways. Therapists suggest tools and techniques to save energy and prevent slips or strain.
Custom splints or ankle-foot supports guide alignment and reduce uneven forces on bones. They can steady weak joints and help delay fatigue during walking or play.
Your genes may have an impact on how drugs work for you
Genes can change how your body handles medicines for osteogenesis imperfecta type 15, affecting drug levels, side effects, and how well treatments like bisphosphonates work. Pharmacogenetic testing and careful dose adjustments help tailor therapy to you and improve safety.
Pharmacological treatments
Medicines for Osteogenesis imperfecta type 15 aim to strengthen bones, lower fracture risk, and ease pain so daily life feels safer and less interrupted. Treatment choices depend on age, fracture history, bone density, and other health factors, and are usually combined with physical therapy and careful activity planning. Not everyone responds to the same medication in the same way. Medicines may be started soon after early symptoms of Osteogenesis imperfecta type 15, such as frequent fractures, are recognized.
Pamidronate or zoledronic acid infusions can increase bone density and reduce fractures in many children with Osteogenesis imperfecta type 15. They are given periodically in hospital or clinic, often every few months. Blood tests and kidney function are monitored, and temporary flu-like symptoms can occur after infusions.
Alendronate or risedronate may be used more often in adolescents and adults. They can help maintain bone strength but must be taken exactly as directed to reduce stomach irritation. People are usually checked regularly for bone density and side effects.
Adequate intake supports bone remodeling and helps other treatments work safely. Doctors often correct low vitamin D and ensure enough calcium, especially when antiresorptive drugs are used. Levels are checked with occasional blood tests.
In selected cases of Osteogenesis imperfecta type 15, this injection may be considered when bisphosphonates are not suitable or have limited effect. It requires close follow-up to prevent low calcium and to manage rebound effects if doses are delayed or stopped. Specialist teams plan dosing and transition carefully.
Genetic influences
In osteogenesis imperfecta type 15, the main genetic driver is changes in a gene called WNT1, which works a bit like a dimmer switch for bone‑building cells. When both copies of WNT1 carry a harmful change, bone strength is reduced from early life, which leads to the frequent fractures and low bone density linked to this condition. The inheritance pattern is autosomal recessive: usually each parent carries one changed copy but is healthy, and with each pregnancy there’s a 25% chance the child will inherit both changes and develop osteogenesis imperfecta type 15. A “carrier” means you hold the gene change but may not show symptoms. Even within the same family, severity can differ because other genes and life factors also shape bone density and fracture risk. Genetic testing for osteogenesis imperfecta type 15 can identify WNT1 changes and confirm the diagnosis, helping guide care and inform relatives about their own chances and reproductive options.
Is Osteogenesis imperfecta type 15 genetic?
Genetics are central in Osteogenesis imperfecta type 15. Pathogenic variants in specific genes disrupt collagen-related pathways, driving bone fragility and related features. Inherited patterns vary by family; genetic testing confirms the diagnosis, informs prognosis, and guides family planning and eligibility for trials.
Pharmacogenetics—how genetics influence drug effects
For people with osteogenesis imperfecta type 15, the gene change driving the condition can also influence how genetics shape treatment choices. WNT1, a gene that helps control bone‑building signals, is affected in this subtype; when that signal is weaker, medicines that depend on it to stimulate new bone may not work as strongly. By contrast, drugs that slow bone breakdown, such as bisphosphonates, are commonly used and can raise bone density and ease bone pain, though fracture benefits vary from person to person.
Genetics is only one factor, and other elements—like age, mobility, vitamin D levels, and kidney function—also guide which drug, dose, and schedule make sense. Typical “drug‑metabolism” gene differences matter less here because many of these bone medicines are not heavily processed by the liver. Researchers are exploring therapies that act directly on WNT signaling; these options are still emerging, so it’s worth asking your specialist about current evidence and whether any are appropriate for you.
Interactions with other conditions
Living with Osteogenesis imperfecta type 15, other health issues can change how often fractures happen, how much things hurt, and how easy it feels to get around. Doctors call it a “comorbidity” when two conditions occur together. When early symptoms of Osteogenesis imperfecta type 15 include frequent low-impact fractures, clinicians often also check for thyroid overactivity, celiac disease or other gut problems that limit nutrient absorption, and vitamin D deficiency, since all of these can further weaken bones. Some medicines—like long-term steroids, certain anti-seizure drugs, and aromatase inhibitors used for breast cancer—may lower bone density too, so care teams usually adjust plans to protect bone. Chest and spine changes can make breathing shallower, so respiratory infections such as flu or pneumonia may feel tougher and take longer to recover from; sleep apnea can add fatigue and slow healing. Ear infections or chronic middle-ear fluid can worsen hearing changes that some people with Osteogenesis imperfecta type 15 already experience, and dental issues may make chewing uncomfortable during flares or after procedures.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described families in which several relatives broke bones from minor bumps, healed quickly but fractured again, and often had short stature. Community stories often described the condition as “glass bones,” reflecting the fragility many noticed in childhood and even at birth. Midwives and doctors wrote about newborns with multiple fractures after routine deliveries, and later, surgeons noted curved legs and spine changes that tended to worsen with growth.
From early theories to modern research, the story of osteogenesis imperfecta type 15 traces a shift from what could be seen on the outside to what happens inside bone. For much of the 20th century, osteogenesis imperfecta (OI) was grouped mainly by how severe it looked—how often fractures happened, whether there was hearing loss, or the color of the whites of the eyes. As medical science evolved, researchers realized that OI is not one single cause but a family of conditions with different genetic changes altering how bone is built and maintained.
In the 2000s and early 2010s, advances in genetics made it possible to go beyond the classic collagen genes and test many genes at once. This opened the door to identifying rarer forms. OI type 15 was first described in the medical literature as a distinct, inherited form when families with frequent childhood fractures, curved long bones, and low bone density were found to share changes in a gene involved in bone strength. The pattern of inheritance helped clinicians recognize that in some families, children were affected when both parents silently carried the same change.
Once considered rare, now recognized as part of the broader OI spectrum, OI type 15 showed that bone fragility can arise from more than collagen alone. Early reports focused on children with multiple fractures and bowed limbs; later descriptions added features like short stature and occasional dental or spine issues, while also noting how much symptoms can vary within the same family. Not every early description was complete, yet together they built the foundation of today’s knowledge.
With each decade, the history of osteogenesis imperfecta type 15 has moved toward earlier diagnosis and more tailored care. Genetic testing now helps confirm the type, guide family planning, and connect people with appropriate therapies and supports. Looking back helps explain why some relatives were told they had “brittle bones” without a clear subtype, while today many can learn the specific type and what that means for monitoring, treatment, and everyday life.